The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALBANY MOLECULAR RESH INC COM 012423109 4,243 302,400 SH   SOLE   302,400 0 0
ALLERGAN PLC SHS G0177J108 3,584 15,000 SH   SOLE   15,000 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 1,440 450,000 SH   SOLE   450,000 0 0
CRYOLIFE INC COM 228903100 2,498 150,000 SH   SOLE   150,000 0 0
DEPOMED INC COM 249908104 1,255 100,000 SH Call SOLE   100,000 0 0
DEPOMED INC COM 249908104 4,393 350,000 SH   SOLE   350,000 0 0
FIBROCELL SCIENCE INC COM PAR 315721308 32 15,923 SH   SOLE   15,923 0 0
FLUIDIGM CORP DEL COM 34385P108 285 50,000 SH Call SOLE   50,000 0 0
FLUIDIGM CORP DEL COM 34385P108 1,565 275,000 SH   SOLE   275,000 0 0
GILEAD SCIENCES INC COM 375558103 4,075 60,000 SH Call SOLE   60,000 0 0
GILEAD SCIENCES INC COM 375558103 5,094 75,000 SH   SOLE   75,000 0 0
IMMUNOMEDICS INC COM 452907108 647 100,000 SH Call SOLE   100,000 0 0
IMPAX LABORATORIES INC COM 45256B101 2,530 200,000 SH Call SOLE   200,000 0 0
NOVELION THERAPEUTICS INC COM NEW 67001K202 8,930 831,440 SH   SOLE   831,440 0 0
PFIZER INC COM 717081103 8,553 250,000 SH   SOLE   250,000 0 0
PROSHARES TR ULTSH NASD BIOT 74347B789 695 25,000 SH Call SOLE   25,000 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103 5,894 25,000 SH Put SOLE   25,000 0 0
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADR 881624209 2,407 75,000 SH   SOLE   75,000 0 0
ZOGENIX INC COM NEW 98978L204 346 31,850 SH   SOLE   31,850 0 0